SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+37.35%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$131M
AUM Growth
+$131M
(+36%)
Cap. Flow
+$6.99M
Cap. Flow
% of AUM
5.35%
Top 10 Holdings %
Top 10 Hldgs %
81.55%
Holding
24
New
7
Increased
6
Reduced
8
Closed
3
Top Buys
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$9.22M |
| 2 |
AYTU BioPharma
AYTU
|
$8.36M |
| 3 |
SCYNEXIS
SCYX
|
$5.24M |
| 4 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
$3.18M |
| 5 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$3.06M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$10.8M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$5.52M |
| 3 |
Gyre Therapeutics
GYRE
|
$3.64M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
$3.26M |
| 5 |
DiaMedica Therapeutics
DMAC
|
$1.99M |
Sector Composition
| 1 | Healthcare | 97.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ligand Pharmaceuticals
LGND
$3.19B
| $32.4M | 24.83% |
326,100
+4,600
| +1% | +$457K |
|
|
AMYT
2
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $20.1M | 15.35% |
1,416,483
+651,247
| +85% | +$9.22M |
|
|
3
DiaMedica Therapeutics
DMAC
$275M
| $9.63M | 7.37% |
950,000
-196,470
| -17% | -$1.99M |
|
|
4
AYTU BioPharma
AYTU
$21.1M
| $8.37M | 6.4% |
+1,398,776
| New | +$8.36M |
|
|
APEN
5
DELISTED
Apollo Endosurgery, Inc.
APEN
| $7.91M | 6.05% |
2,326,165
+900,730
| +63% | +$3.06M |
|
|
CTIC
6
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $6.61M | 5.06% |
2,054,000
-1,714,597
| -45% | -$5.52M |
|
|
ISEE
7
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.53M | 4.23% |
800,000
-1,562,240
| -66% | -$10.8M |
|
8
Xoma
XOMA
$420M
| $5.48M | 4.19% |
124,130
-26,083
| -17% | -$1.15M |
|
|
9
Gyre Therapeutics
GYRE
$700M
| $5.27M | 4.03% |
834,449
-576,963
| -41% | -$3.64M |
|
|
10
SCYNEXIS
SCYX
$35M
| $5.24M | 4.01% |
+685,000
| New | +$5.24M |
|
|
ADMS
11
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $3.5M | 2.68% |
808,431
+150,964
| +23% | +$654K |
|
|
SBBP
12
DELISTED
Strongbridge Biopharma plc.
SBBP
| $3.28M | 2.51% |
1,350,000
-574,956
| -30% | -$1.4M |
|
|
GMDA
13
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $3.18M | 2.44% |
+379,470
| New | +$3.18M |
|
|
CHMA
14
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $3.14M | 2.4% |
721,307
+371,307
| +106% | +$1.62M |
|
|
NEOS
15
DELISTED
Neos Therapeutics, Inc
NEOS
| $3.1M | 2.37% |
4,962,657
+578,458
| +13% | +$361K |
|
16
Eledon Pharmaceuticals
ELDN
$153M
| $2.58M | 1.97% |
+167,333
| New | +$2.58M |
|
|
KA
17
DELISTED
Kineta, Inc. Common Stock
KA
| $1.85M | 1.42% |
+108,847
| New | +$1.85M |
|
|
AFMD
18
DELISTED
Affimed
AFMD
| $1.28M | 0.98% |
219,340
-138,326
| -39% | -$805K |
|
19
VistaGen Therapeutics
VTGN
$108M
| $970K | 0.74% |
+500,000
| New | +$970K |
|
20
Aptevo Therapeutics
APVO
$5.26M
| $670K | 0.51% |
+18,280
| New | +$670K |
|
21
Cumberland Pharmaceuticals
CPIX
$55.2M
| $557K | 0.43% |
188,703
-400,794
| -68% | -$1.18M |
|
|
BIOR
22
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| – | – |
-68,062
| Closed | -$614K |
|
|
ATRS
23
DELISTED
Antares Pharma, Inc.
ATRS
| – | – |
-1,205,501
| Closed | -$3.26M |
|
|
IDXG
24
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| – | – |
-284,730
| Closed | -$880K |
|